FDA granted designation for a drug under Gibbs' leadership, involving GSK and Gilead Sciences.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted designation for a drug under Gibbs' leadership, involving GSK and Gilead Sciences.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GSK
British multinational pharmaceutical and biotechnology company
-
Gilead Sciences
American company
- FDA